Our new t-test suggested a greater increase in C5aR1-levels at onset and a smaller decrease in IgG-levels after recovery in COVID-19 patients than non-COVID-19 patients, which were not detected by conventional statistical tests. The gene discussed is C5AR1; the disease is COVID-19.